You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • OP0095 Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor-alfa monoclonal antibody (infliximab) in persistently active refractory juvenile idiopathic (chronic) arthritis. an one year open prospective pilot study

Citation Tools

Article menu
Download PDFPDF
Speaker abstracts 2001
Pediatric rheumatology
OP0095 Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor-alfa monoclonal antibody (infliximab) in persistently active refractory juvenile idiopathic (chronic) arthritis. an one year open prospective pilot study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gerloni V, Pontikaki I, Desiati F, et al
OP0095 Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor-alfa monoclonal antibody (infliximab) in persistently active refractory juvenile idiopathic (chronic) arthritis. an one year open prospective pilot study
Annals of the Rheumatic Diseases 2001;60:A198.